Cargando…
Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease
Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for many months. We delineated the immune-proteomic landscape in the airways and peripheral blood of healthy controls and post-COVID-19 patients 3 to 6 months after hospital discharge. Post-COVID-19 patients show...
Autores principales: | Vijayakumar, Bavithra, Boustani, Karim, Ogger, Patricia P., Papadaki, Artemis, Tonkin, James, Orton, Christopher M., Ghai, Poonam, Suveizdyte, Kornelija, Hewitt, Richard J., Desai, Sujal R., Devaraj, Anand, Snelgrove, Robert J., Molyneaux, Philip L., Garner, Justin L., Peters, James E., Shah, Pallav L., Lloyd, Clare M., Harker, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789571/ https://www.ncbi.nlm.nih.gov/pubmed/35151371 http://dx.doi.org/10.1016/j.immuni.2022.01.017 |
Ejemplares similares
-
CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after
Hospital Discharge
por: Vijayakumar, Bavithra, et al.
Publicado: (2021) -
Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease
por: Boustani, Karim, et al.
Publicado: (2022) -
Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021) -
Not All Parenchymal Changes on Computed Tomography Are Interstitial Lung Disease
por: Vijayakumar, Bavithra, et al.
Publicado: (2021) -
A Not-So-Good Way to Die? Respiratory Syncytial Virus–induced Necroptotic Cell Death Promotes Inflammation and Type 2–mediated Pathology
por: Harker, James A., et al.
Publicado: (2020)